Table 1.
Summary of demographic and clinical characteristics and management of cases of parotitis with an identified aetiological agent.
Variable n (%)a |
Mumps virusb n = 18 (38.3%)c |
EBV n = 21 (44.7%)c |
CMV n = 11 (23.4%)c |
Influenza A H3N2 n = 6 (12.8%)c |
Parainfluenza 2 and 3 n = 4 (8.5%)c |
Total with aetiological diagnosis n = 47 |
---|---|---|---|---|---|---|
Female sex; n (%) | 5 (27.8) | 5 (23.8) | 3 (27.2) | 3 (50) | 0 (0) | 14 (30) |
Median age; (range) | 14.3 (1.5−16.8)d | 7.5 (1.5−14.9)d | 7.5 (1.4−14.4)d | 11.6 (6.5−13.6)d | 2.6 (0.9−4.8)d | 8.58 (0.9−16.8)d |
Bilateral involvement; n (%) | 2 (11.1) | 3 (14.3) | 2 (18.2) | 2 (33.3) | 0 (0) | 6 (12.8) |
Submandibular swelling; n (%) | 3 (16.6) | 4 (19.0) | 3 (27.2) | 3 (50) | 0 (0) | 10 (21.3) |
Reported pain; n (%) | 13 (72.2) | 10 (47.6) | 8 (72.7) | 5 (83.3) | 1 (25) | 30 (63.8) |
Preceding or concomitant cold symptoms; n (%) | 4 (22.2) | 2 (9.5) | 1 (9.1) | 1 (16.7) | 0 (0) | 7 (14.8) |
Significant lymphadenopathy; n (%) | 5 (27.8) | 9 (42.8) | 4 (36.4) | 2 (33.3) | 1 (25) | 15 (31.9) |
Fever; n (%) | 13 (72.2) | 12 (57.1) | 4 (36.4) | 2 (33.3) | 0 (0) | 25 (53.2) |
Cough; n (%) | 2 (11.1) | 3 (14.3) | 1 (9.1) | 3 (50) | 2 (50) | 9 (19.1) |
Painful swallowing; n (%) | 4 (22.2) | 2 (9.5) | 2 (18.2) | 1 (16.7) | 0 (0) | 6 (12.8) |
Blood tests based on clinician’s judgment; n (%) | 11 (61.2) | 10 (47.6) | 7 (63.6) | 4 (66.7) | 2 (50) | 27 (57.4) |
Empiric antibiotherapy; n (%) | 3 (16.6) | 3 (14.3) | 2 (18.2) | 3 (50) | 0 (0) | 9 (19.1) |
Hospital admission; n (%) | 1 (5.5) | 1 (4.8) | 2 (18.2) | 0 (0) | 0 (0) | 3 (6.4) |
CMV, cytomegalovirus; EBV, Epstein-Barr virus.
Total: 47 patients, corresponding to 35.1% of the total patients that underwent some form of testing for aetiological investigation.
The columns devoted to each individual virus include all patients with a positive test result for that virus, including cases of coinfection.
Percentage of the total patients with a positive test for the virus corresponding to the column.
Of the 18 cases: 13 diagnosed by PCR on saliva samples and 5 by antibody testing.
Percentage of total patients with an etiological diagnosis.
Age in years.